William E. Schreiber
University of British Columbia
35 Papers
302 Citations
William E. Schreiber is an academic researcher from University of British Columbia. The author has contributed to research in topics: Acute intermittent porphyria & Porphobilinogen deaminase. The author has an hindex of 15, co-authored 34 publications. Previous affiliations of William E. Schreiber include Vancouver Hospital and Health Sciences Centre & Vancouver General Hospital.
Chat about Author
Papers
Cannabis use as a risk factor for causing motor vehicle crashes: a prospective study.
Jeffrey R. Brubacher,Herbert Chan,Shannon Erdelyi,Scott Macdonald,Mark Asbridge,Robert E. Mann,Jeffrey Eppler,Adam Lund,Andrew MacPherson,Walter Martz,William E. Schreiber,Rollin Brant,Roy Purssell +12 more
TL;DR: A responsibility analysis to determine whether drivers injured in motor vehicle collisions who test positive for Δ‐9‐tetrahydrocannabinol (THC) or other drugs are more likely to have contributed to the crash than those who test negative found no evidence of increased crash risk in non‐fatally injured motor vehicle drivers.
120
Incomplete testosterone suppression with luteinizing hormone-releasing hormone agonists: does it happen and does it matter?
TL;DR: In this paper, the authors used a large dataset of 2196 men, and confirmed incomplete testosterone suppression (breakthrough) rates >1.1 and 1.7 nmol/L with LHRH agonists.
63
MUC1 Gene–Derived Glycoprotein Assays for Monitoring Breast Cancer (CA 15-3, CA 27.29, BR): Are They Measuring the Same Antigen?
TL;DR: Many of the test value differences for these measurements are due to differences in assay calibration rather than differences in the specificity of the assay measurement systems, indicating that across-method assay differences hinder the exchange of patient test values.
55
A rapid and accurate spectrofluorometric method for quantification and screening of urinary porphyrins.
TL;DR: A rapid, sensitive screen for porphyrinuria as well as an accurate and precise quantitative method that compared the method with existing methods and discussed some shortcomings common to many of them.
47
Heteroduplex analysis detects frameshift and point mutations in patients with acute intermittent porphyria.
TL;DR: The spectrum of mutations that cause AIP is extended and the utility of heteroduplex analysis as a screening technique is demonstrated, as well as the potential of direct sequencing of polymerase chain reaction products to investigate unique banding patterns.
39